Variant report
Variant | nsv438088 |
---|---|
Chromosome Location | chr9:1510299-1526383 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10491859 | chr9:1510299-1510300 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs12348788 | chr9:1510314-1510315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs73640491 | chr9:1510347-1510348 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs368449107 | chr9:1510361-1510362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs184974911 | chr9:1510363-1510364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs71511865 | chr9:1510382-1510383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs371240993 | chr9:1510388-1510389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs545816230 | chr9:1510428-1510429 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs73376155 | chr9:1510431-1510432 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs115746905 | chr9:1510435-1510436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs73640493 | chr9:1510440-1510441 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs73376157 | chr9:1510455-1510456 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs143750225 | chr9:1510458-1510459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548201660 | chr9:1510467-1510468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs550885988 | chr9:1510477-1510478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs10491858 | chr9:1510495-1510496 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs189046929 | chr9:1510498-1510499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs547017852 | chr9:1510540-1510541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs373966773 | chr9:1510550-1510551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs566804619 | chr9:1510559-1510560 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs7872925 | chr9:1510568-1510569 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs386731561 | chr9:1510588-1510589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs7859562 | chr9:1510590-1510591 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs537268773 | chr9:1510630-1510631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs557275621 | chr9:1510691-1510692 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs577248929 | chr9:1510700-1510701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs552114952 | chr9:1510701-1510702 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs552938639 | chr9:1510715-1510716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs375448912 | chr9:1510718-1510719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs538092404 | chr9:1510727-1510728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs386731562 | chr9:1510745-1510746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs541927108 | chr9:1510747-1510748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs181714003 | chr9:1510750-1510751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs199576273 | chr9:1510751-1510752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs144093272 | chr9:1510755-1510756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs7873207 | chr9:1510756-1510757 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs564435875 | chr9:1510806-1510807 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs533680554 | chr9:1510815-1510816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs7859922 | chr9:1510819-1510820 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs56376334 | chr9:1510832-1510833 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs114097698 | chr9:1510847-1510848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs10810324 | chr9:1510848-1510849 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs141145425 | chr9:1510852-1510853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs150757637 | chr9:1510864-1510865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs184833840 | chr9:1510865-1510866 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs10810325 | chr9:1510881-1510882 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs7859951 | chr9:1510885-1510886 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs56400363 | chr9:1510887-1510888 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs189543938 | chr9:1510888-1510889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs566353780 | chr9:1510898-1510899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Pilomyxoid astrocytoma | 18622384 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Gastric cancer | 16715143 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 20531469 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Esophageal cancer | 21851588 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:1504800-1513800 | Weak transcription | Adipose Nuclei | Adipose |
2 | chr9:1511000-1511200 | Enhancers | NHEK | skin |
3 | chr9:1512600-1513000 | Enhancers | Fetal Muscle Leg | muscle |
4 | chr9:1512800-1514200 | Enhancers | NHEK | skin |
5 | chr9:1513000-1513400 | Weak transcription | Fetal Muscle Leg | muscle |
6 | chr9:1513000-1513800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
7 | chr9:1513200-1514000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
8 | chr9:1513400-1514800 | Enhancers | Fetal Muscle Leg | muscle |
9 | chr9:1513800-1514600 | Enhancers | Adipose Nuclei | Adipose |
10 | chr9:1514000-1514800 | Enhancers | Psoas Muscle | Psoas |
11 | chr9:1514400-1515000 | Enhancers | Fetal Stomach | stomach |
12 | chr9:1514400-1515800 | Enhancers | GM12878-XiMat | blood |
13 | chr9:1514600-1522600 | Weak transcription | Adipose Nuclei | Adipose |
14 | chr9:1514800-1521600 | Weak transcription | Fetal Muscle Leg | muscle |
15 | chr9:1515000-1515600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
16 | chr9:1515600-1516000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
17 | chr9:1515600-1516000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
18 | chr9:1515600-1516000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
19 | chr9:1515800-1516200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
20 | chr9:1521600-1522200 | Enhancers | Fetal Muscle Leg | muscle |
21 | chr9:1521600-1523600 | Enhancers | GM12878-XiMat | blood |
22 | chr9:1521800-1523000 | Enhancers | Fetal Lung | lung |
23 | chr9:1522200-1522600 | Weak transcription | Fetal Muscle Leg | muscle |
24 | chr9:1522600-1523400 | Enhancers | Fetal Muscle Leg | muscle |
25 | chr9:1522600-1523800 | Enhancers | Adipose Nuclei | Adipose |
26 | chr9:1523400-1527800 | Weak transcription | Fetal Muscle Leg | muscle |